TCF7L2基因多态性与妊娠糖尿病的相关性研究
|
摘要
研究目的
遗传学和流行病学研究均表明,妊娠糖尿病和2型糖尿病之间具有一定的相关性,二者均是多基因多因素所致的疾病,以胰岛素抵抗和胰岛素分泌功能受损为特征。最近发现,TCF7L2基因多态性与2型糖尿病显著关联。本次实验旨在研究TCF7L2基因的rs290487C/T、rs11196205C/G和rs11196218A/G在妊娠糖尿病孕妇和正常孕妇中的分布频率,探讨TCF7L2基因在妊娠糖尿病遗传易感性中的作用。
研究方法
本次实验共收集受试者1140例,其中50g葡萄糖负荷试验(GCT)正常者274例,GCT阳性受试者866例,GCT阳性受试者进一步行100g口服葡萄糖耐量试验(OGTT),其中正常373例,IGT患者158例,GDM患者335例,将GCT阴性与NGT者合并为对照组,IGT与GDM者合并为病例组。在所有受试者中用连接酶检测反应确定基因型。
结果
1.在所有受试者中,TCF7L2基因rs290487C/T位点CC、CT及TT三种基因型分布频率分别为16.02%、45.18%及38.79%;rs11196205C/G位点GG、CG基因型分布频率为95.46%、4.54%,未发现CC基因型者;rs11196218A/G位点AA、AG及GG基因型分布频率分别为6.66%、41.70%及51.64%。
2.TCF7L2基因rs290487C/T在病例组中三种基因型分布与对照组比较,差异有显著性(x~2=6.490,P=0.039);CC+CT基因型频率在病例组中显著高于对照组(x~2=4.082,P=0.043),病例组的C等位基因频率高于对照组,两者比较有统计学意义(x~2=6.358,P=0.0117);rs11196205C/G及rs11196218A/G位点各基因型分布及等位基因频率在病例组和对照组间无差别。
3.TCF7L2基因rs290487C/T、rs11196205C/G和rs11196218A/G位点各基因型间临床资料及生化指标比较,差异未见显著性。
4.三个位点的连锁不平衡分析显示,rs11196205及rs11196218两个位点不完全连锁(D'=0.218),rs11196205与rs290487两点亦是不完全连锁(D'=0.345)。
5.Logistic回归分析显示,TCF7L2基因rs290487的CC基因型者发生妊娠糖尿病的危险是T等位基因携带者的1.23倍,年龄、糖尿病家族史、体质指数、超敏C反应蛋白均为发生高血糖的独立危险因素。
结论
TCF7L2基因rs290487C/T、rs11196205C/G和rs11196218A/G位点在中国汉族人群中存在多态性;rs290487位点CC+CT基因型频率在妊娠糖尿病组中明显高于正常孕妇组,CC基因型是血糖升高的危险因素。
Objective
Genetic and epidemiological studies suggest an association between gestational diabetes mellitus and type 2 diabetes.Both are polygetic multifactorial disorders characterized by beta cell dysfunction and insulin resistance.Gene polymorphisms of the transcription factor 7-like 2(TCF7L2) gene have been reported to be associated with type 2 diabets mellitus.Our aim was to investigate whether common genetic variants that have previously been associated with type 2 diabetes or related phenotypes would also confer risk for gestational diabetes mellitus.
Methods
In 1140 unrelated pregnant Chinese women(493 women with gestational diabetes mellitus, 647 non-diabetic control subjects) we genotyped the transcription factor 7-like 2 rs290487, rs11196205 and rs11196218 using ligase detection reaction.
Results
The CC,CT and TT genotype frequencies of TCF7L2 rs290487 position in Beijing residents were 16.02%、45.18%and 38.79%;And the frequency of GG and CG genotype of TCF7L2 rs11196205 position were 95.46%、4.54%;And the frequency of AAAG and GG genotype of TCF7L2 rs11196218 position were 6.66%、41.70%及51.64%.The CC,CT and TT genotype frequencies of the TCF7L2 rs290487 variant differed significantly between women with gestational diabetes mellitus and control women(18.75%,45.83%and 35.42%vs 13.95%, 44.69%and 41.36%,x~2=6.49,p=0.039).Homozygous(CC-genotype) and heterozygous (CT-genotype) carriers in gestational diabetes mellitus group were higher than those in non-GDM group(x~2=4.082,P=0.043).Compared with T-allele carriers,the CC-genotype carriers had a 1.23-fold(95%CI 1.021-1.962,p=0.042) increased risk of gestational diabetes mellitus.NO differences of the genotype and allelic frequencies at rs11196205 and rs11196218 were observed between the cases and the controls.
Conclusions
There were polymorphisms of the transcription factor 7-like 2 gene rs290487C/T,rs11196205C/G and rs11196218A/G in Chinese population from Beijing residents.Homozygous(CC-genotype) and heterozygous(CT-genotype) carriers of TCF7L2 rs290487 variant in gestational diabetes mellitus group were higher than those in non-GDM group.The TCF7L2 rs290487 variant is associated with an increased risk of gestational diabetes mellitus in Chinese women.
遗传学和流行病学研究均表明,妊娠糖尿病和2型糖尿病之间具有一定的相关性,二者均是多基因多因素所致的疾病,以胰岛素抵抗和胰岛素分泌功能受损为特征。最近发现,TCF7L2基因多态性与2型糖尿病显著关联。本次实验旨在研究TCF7L2基因的rs290487C/T、rs11196205C/G和rs11196218A/G在妊娠糖尿病孕妇和正常孕妇中的分布频率,探讨TCF7L2基因在妊娠糖尿病遗传易感性中的作用。
研究方法
本次实验共收集受试者1140例,其中50g葡萄糖负荷试验(GCT)正常者274例,GCT阳性受试者866例,GCT阳性受试者进一步行100g口服葡萄糖耐量试验(OGTT),其中正常373例,IGT患者158例,GDM患者335例,将GCT阴性与NGT者合并为对照组,IGT与GDM者合并为病例组。在所有受试者中用连接酶检测反应确定基因型。
结果
1.在所有受试者中,TCF7L2基因rs290487C/T位点CC、CT及TT三种基因型分布频率分别为16.02%、45.18%及38.79%;rs11196205C/G位点GG、CG基因型分布频率为95.46%、4.54%,未发现CC基因型者;rs11196218A/G位点AA、AG及GG基因型分布频率分别为6.66%、41.70%及51.64%。
2.TCF7L2基因rs290487C/T在病例组中三种基因型分布与对照组比较,差异有显著性(x~2=6.490,P=0.039);CC+CT基因型频率在病例组中显著高于对照组(x~2=4.082,P=0.043),病例组的C等位基因频率高于对照组,两者比较有统计学意义(x~2=6.358,P=0.0117);rs11196205C/G及rs11196218A/G位点各基因型分布及等位基因频率在病例组和对照组间无差别。
3.TCF7L2基因rs290487C/T、rs11196205C/G和rs11196218A/G位点各基因型间临床资料及生化指标比较,差异未见显著性。
4.三个位点的连锁不平衡分析显示,rs11196205及rs11196218两个位点不完全连锁(D'=0.218),rs11196205与rs290487两点亦是不完全连锁(D'=0.345)。
5.Logistic回归分析显示,TCF7L2基因rs290487的CC基因型者发生妊娠糖尿病的危险是T等位基因携带者的1.23倍,年龄、糖尿病家族史、体质指数、超敏C反应蛋白均为发生高血糖的独立危险因素。
结论
TCF7L2基因rs290487C/T、rs11196205C/G和rs11196218A/G位点在中国汉族人群中存在多态性;rs290487位点CC+CT基因型频率在妊娠糖尿病组中明显高于正常孕妇组,CC基因型是血糖升高的危险因素。
Objective
Genetic and epidemiological studies suggest an association between gestational diabetes mellitus and type 2 diabetes.Both are polygetic multifactorial disorders characterized by beta cell dysfunction and insulin resistance.Gene polymorphisms of the transcription factor 7-like 2(TCF7L2) gene have been reported to be associated with type 2 diabets mellitus.Our aim was to investigate whether common genetic variants that have previously been associated with type 2 diabetes or related phenotypes would also confer risk for gestational diabetes mellitus.
Methods
In 1140 unrelated pregnant Chinese women(493 women with gestational diabetes mellitus, 647 non-diabetic control subjects) we genotyped the transcription factor 7-like 2 rs290487, rs11196205 and rs11196218 using ligase detection reaction.
Results
The CC,CT and TT genotype frequencies of TCF7L2 rs290487 position in Beijing residents were 16.02%、45.18%and 38.79%;And the frequency of GG and CG genotype of TCF7L2 rs11196205 position were 95.46%、4.54%;And the frequency of AAAG and GG genotype of TCF7L2 rs11196218 position were 6.66%、41.70%及51.64%.The CC,CT and TT genotype frequencies of the TCF7L2 rs290487 variant differed significantly between women with gestational diabetes mellitus and control women(18.75%,45.83%and 35.42%vs 13.95%, 44.69%and 41.36%,x~2=6.49,p=0.039).Homozygous(CC-genotype) and heterozygous (CT-genotype) carriers in gestational diabetes mellitus group were higher than those in non-GDM group(x~2=4.082,P=0.043).Compared with T-allele carriers,the CC-genotype carriers had a 1.23-fold(95%CI 1.021-1.962,p=0.042) increased risk of gestational diabetes mellitus.NO differences of the genotype and allelic frequencies at rs11196205 and rs11196218 were observed between the cases and the controls.
Conclusions
There were polymorphisms of the transcription factor 7-like 2 gene rs290487C/T,rs11196205C/G and rs11196218A/G in Chinese population from Beijing residents.Homozygous(CC-genotype) and heterozygous(CT-genotype) carriers of TCF7L2 rs290487 variant in gestational diabetes mellitus group were higher than those in non-GDM group.The TCF7L2 rs290487 variant is associated with an increased risk of gestational diabetes mellitus in Chinese women.
引文
[1]Harris SB,Caulfield LE, Sugamori ME, et al.,The epidemiology of diabetes in pregnant native Canadians. Diabetes Care. 1997, 20:1422-1425.
[2]Cheung NW, Byth K. Population health significance of gestational diabetes. Diabetes Care,2003,26:2005-2009.
[3]Grant SF, Thorleifsson G, Reynisdottir I et al. Variant of transcription 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006,38:320-323.
[4]Yi F, Brubaker PL, Jin T: TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 2005,280:1457-1464.
[5]Chang YC, Chang TJ, Jiang YD, et al. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population.Diabetes. 2007,56:2631-2637.
[6]Maggic CY, Claudia HT, Vincent KL, et al. Replication and identification of novel variants at TCF7L2 associated with type 2 diabetes in Hong Kong Chinese. J Clin Endocrinol Metab.2007 Sep;92:3733-3737.
[7]Berkowitz GS, Lapinski RH, WeinR, et al. Race/ethnicity and other risk factors for gestational diabetes.Am J Eidemiol. 1992,135:965.
[8]Wolf M, Sandier L, Hsu K,et al. First-trimester C-reactive Protein and subsequent gestational diabetes.Diabetes Care, 2003,26(3):819-824.
[9]Qiu C,Vadachkofia S,Meryman L,et al.,Maternal plasma concentrations of IGF—1,IGFBP—1, and C—peptide in early pregnancy and subsequent risk of gestational diabetes mellitus.Am J Obstet.Gynecol. 2005,193:1691—1697.
[10]Qiu C,Sorenscn TK,Luthy DA,et al.A prospective study of matermal serum C-reactive protein(CRP) concentrations and risk ofgestational diabetes meallitus Paediat Perinat Epidemiol,2004,18(5): 377-384.
[11]American National Diabetes Data Group.Diabetes 1979,28:1039.
[12]Manson JE,Rimm EB,Colditz GA,et al.Parity and incidence of non-Insulin-dependent- diabetes.Am J Med.,1992,93:13-18.
[13]Homko C,Sivan E,Chen X,et al.Insulin secretion during and after pregnancy in patients with gestational diabetes mellituso J Clin Endocrinol Metab,2001,86(2):568-573.
[14]Buchanan TA,Xiang A,Kjos SL,et.al,Gestational diabetes:antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women,Diabetes,1998,47:1302-1310.
[15]Martin L,Schwartz MD,Wendy NR,et al.The diagnosis and classification of gestational diabetes mellitus:Is it time to change our tune?Am.J.Obstet.Gynecol,1999,180:1560-1571.
[16]Vercellini P,Zuliani G.Pregnancy at forty and over:a case-control study.Eur J Obstet Gynecol Reprod Biol,1993;48:191.
[17]Meier JJ,Nauck MA Glucagon-like peptide 1(GLP-1) in biology and pathology.Diabetes Metab Res Rev.2005,21:91-117.
[18]Sch(a|¨)fer SA,.Tschritter F.,Machicao C et al.,Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2(TCF7L2) gene polymorphisms.Diabetologia 2007;50:2443-2450.
[19]Solomon CG,Willett WC,Carey VJ,et al.,A prospective study of pregnant determinants of gestational diabetes mellitus.JAMA.1997,278:1078-1083.
[20]Martin L,Schwartz MD,Wendy NR,et al.The diagnosis and classification of gestational diabetes mellitus:Is it time to change our tune?Am.J.Obstet.Gynecol,1999,180:1560-1571.
[21]Siribaddana SH,Deshabandu R,Rajapakse D,et al.The prevalence of gestational diabetes in a Sri lankan antenatal clinic.Ceylon.Med.J,1998,43:88-91.
[22]曹泽毅,主编.中华妇产科学[M].北京:人民卫生出版社,1999:508-513.
[23]Florez JC,Jablonski KA,Bayley N et al TCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program.N Engl J Med 2006,355:241-250.
[24]Groves CJ,Zeggini E,Minton J et al Association Analysis of 6,736 UK subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk.Diabetes 2006,55:2640-2644.
[25]Zhang C,Qi L,Hunter DJ et al Variant of transcription factor 7-like 2(TCF7L2) gene and the risk of type 2 diabetes in large cohorts of US women and men.Diabetes 2006, 55:2645-2648. (37) Damcott CM, Pollin TI, Reinhart LJ et al Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish:replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 2006,55:2654-2659.
[26] Scott LJ, Bonnycastle LL, Wilier CJ et al Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 2006,55:2649-2653.
[27]Cauchi S, Meyre D, Dina C et al Transcription factor TCF7L2 genetic study in the French population: expression in human p-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006,55:2903-2908.
[28]Saxena R, Gianniny L, Burtt NP et al Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 2006, 55:2890-2895.
[29]Weedon MN, McCarthy MI, Hitman G et al. Combining information from common type 2 diabetes risk polymorphismsimproves disease prediction. PLoS Med 2006, 3:1-6.
(1) Avery MD, Rossi MA, et al., Gestational diabetes mellitus. J Midwifery, 1994; 39(2 suppl): 9s
(2) Dornhorst A, Paterson CM, Nicholls JSD, et al. High prevalence of gestational diabetes in women from ethnic minority groups. Diabet. Med. 1992; 9: 820-825)
(3) 杨慧霞,董悦,加强对妊娠合并糖尿病的临床研究,中华妇和科杂志,2003,38(3):129。
(4) Homko C,Sivan E,Chen X,et al. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus。 J Clin Endocrinol Metab,2001,86(2):568-573.
(5) Buchanan TA, Xiang A, Kjos SL, et.al, Gestational diabetes:antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women, Diabetes,1998,47: 1302-1310.
(6) YuraS,SagawaN,ItohH,et al., Resistin is expressed in the human placental J Clin Endocrinol Metab,2003,88:139421397.
(7) Martin A.O., Simpson.J.L., Ober.C, et al., Frequency of diabetes Mellitus in mothers of probands with gestational diabetes:possible maternal influence on the predisposition to gestational diabetes,Am J Obstet Gynecol,1985,151:471-475.
(8) PettitD., Aleck K.,Baird H., et al, Congenital susceptibility to NIDDM: role of intrauterine environment J Diabetes, 1988,37(7): 622.
(9) Harder T, Plagemann A,. A role for gestational diabetes in the excess maternal transmission of type 2 diabetes. Diabetes Care, 2000,23(4):431.
(10) Llard S, Beards F, Allen LI,et al., A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria Diabetologia, 2000,43(2): 250-253.
(11) Sagen JV, Baumann ME, Salvesen HB, et al., Diagnostic screening of MODY6 in subjects with MODY or gestational diabetes mellitus. Diabet. Med. 2005,22(8): 1012-1015.
(12) Shaat N, Ekelund M, Lernmark A, et al., Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus. Diabetologia, 2005,48(12):2544-2551.
(13) Rissanen J, Markkanen A, Karkkainen P, et al.,Sulfonylurea receptor gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care, 2000,23(1): 70-73.
(14)Horikawa Y, Oda N, Cox NJ, et al., Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 2000,26(2): 163-175.
(15) Leipold H, Knofler M, Gruber C, et al.,Calpain-10 haplotype combination and association with gestational diabetes mellitus. Obstet. Gynecol. 2004,103(6): 1235-1240.
(16) Alevizaki M,Thalassinou L, Grigorakis SI, et al., Study of the Trg64Arg polymorphism of the beta3-adrenergic receptor in Greek women with gestational diabetes. Diabetes Care,2000,23(8): 1079-1083.
(17) Weedon MN, Schwarz PE, Horikawa Y, et al., Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am J Hum.Genet., 2003, 73(5): 1208-1212.
( 18 ) Festa A, Krugluger W, Shnawa N, et al., Trg64Arg polymorphism of the beta3-adrenergic receptor gene in pregnancy: association with mild gestational diabetes mellitus. J Clin. Endocrinol. Metab., 1999, 84(5): 1695-1699.
(19) Fallucca F, Dalfra MG, Sciullo E, et al., Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy.Metabolism, 2006, 55(11):1451-1456.
(20) Megia A, Gallart L, Fernandez-Real JM, et al., Mannose-binding lectin gene polymorphisms are associated with gestational diabetes mellitus. J Clin. Endocrinol Metab.,2004, 89(10): 5081-5087.
(21) Garcia-Laorden MI, Rua-Figueroa I, Perez-Aciego P, et al., Mannose binding lectin polymorphisms as a disease-modulating fractor in women with systemic lupus erythematosus from Canary Islands,Spain. J Rheumatol. 2003, 30(4):740-746.
(22) Kruse C, Rosgars A, Stefensen R, et al., Lowserum level of mannan binding lectin is a determinant for pregnancy outcome in women with recurrent spontaneous absortion. Am J Obstet Gynecol. 2002, 187(5): 1313-1320.
(23) Duval A, Busson-Leconiat M, Berger R, et al. Assignment of the TCF-4 gene(TCF7L2) to human chromosome band 10q25.3. Cytogenet Cell Genet 2000, 88:264-265.
(24) Duval A. et al. The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings,and mutational analysis in colorectal cancer cell lines. Cancer Res.2000,60: 3872-3879.
(25) Huelsken, J. Birchmeier, W. New aspects of Wnt signaling pathways in higher vertebrates. Curr. Opin. Genet. Dev. 2001, 11: 547-553.
(26) Etheridge SL, Spencer GJ, Heath DJ, et al. Expression profiling and functional analysis of Wnt signaling mechanisms in mesenchymal stem cells. Stem cells 2004;22:849-860.
(27) Yi F, Brubaker PL, Jin T: TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 2005,280:1457-1464.
(28) Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA: Inhibition of adipogenesis by Wnt signaling. Science 2000,289:950 -953.
(29) Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW, Harrison SD,MacDougald OA: Regulation of Wnt signaling during adipogenesis. J Biol Chem 2002,277:30998-31004.
(30) van de Wetering M, Sancho E, Verweij C et al The betacatenin/ TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cell. Cell 2002, 111:241-250.
(31) Jiang Y, Zhou XY, Liu YK, et al. Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma. World J Gastroenterol 2002, 8:804-807.
(32) Papadopoulou S, Edlund H, Edlund H, Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function. Diabetes 2005;54:2844-2851.
(33) Grant SF, Thorleifsson G, Reynisdottir I et al. Variant of transcription 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006,38:320-323.
(34) Florez JC, Jablonski KA, Bayley N et al TCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program. N Engl J Med 2006, 355:241-250.
(35) Groves CJ, Zeggini E, Minton J et al Association Analysis of 6,736 UK subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 2006, 55:2640-2644.
(36) Zhang C, Qi L, Hunter DJ et al Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of US women and men. Diabetes 2006, 55:2645-2648. (37) Damcott CM, Pollin TI, Reinhart LJ et al Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish:replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 2006,55:2654-2659.
(38) Scott LJ, Bonnycastle LL, Wilier CJ et al Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 2006,55:2649-2653.
(39) Cauchi S, Meyre D, Dina C et al Transcription factor TCF7L2 genetic study in the French population: expression in human β-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006,55:2903-2908.
(40) Saxena R, Gianniny L, Burtt NP et al Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 2006, 55:2890-2895.
(41) Weedon MN, McCarthy MI, Hitman G et al. Combining information from common type 2 diabetes risk polymorphismsimproves disease prediction. PLoS Med 2006, 3:1-6.
(42) Loos RJF, Franks PW,Francis RW, et al., TCF7L2 polymorphisms modulate proinsulin levels and 8-cell function in a British Europid population. Diabetes 2007; 56:1943-1947.
(43) Munoz J, Lok KH, Gower BA, et al., Polymorphism in the transcription factor 7-like 2 gene is associated with reduced insulin secretion in non-diabetic women. Diabetes 2006;55:3630-3634.
(44) Freathy RM, Weedon MN, Bennett A, et al., Type 2 diabetes TCF7L2 risk genotypes alter birth weight:a study of 24053 individuals. Am J Hum Genet 2007;80:l 150-1161.
(45) Korinek V, Barker N, Morin PJ, et al., Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997,275:1784-1787.
(46) Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW:Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.Science 1997,275:1787-1790.
(47) Batlle E, Henderson JT, Beghtel H, et al., Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB / ephrinB. Cell 2002,111:251-263.
(48) Korinek V,Barker N,Moerer P,et al.,Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4.Nat Genet 1998,19:379-383.
(49) Meier JJ,Nauck MA Glucagon-like peptide 1(GLP-1) in biology and pathology.Diabetes Metab Res Rev2005,21:91-117.
(50) Sch(a|¨)fer SA,.Tschritter F.,Machicao C et al.,Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2(TCF7L2) gene polymorphisms.Diabetologia 2007;50:2443-2450.
[2]Cheung NW, Byth K. Population health significance of gestational diabetes. Diabetes Care,2003,26:2005-2009.
[3]Grant SF, Thorleifsson G, Reynisdottir I et al. Variant of transcription 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006,38:320-323.
[4]Yi F, Brubaker PL, Jin T: TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 2005,280:1457-1464.
[5]Chang YC, Chang TJ, Jiang YD, et al. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population.Diabetes. 2007,56:2631-2637.
[6]Maggic CY, Claudia HT, Vincent KL, et al. Replication and identification of novel variants at TCF7L2 associated with type 2 diabetes in Hong Kong Chinese. J Clin Endocrinol Metab.2007 Sep;92:3733-3737.
[7]Berkowitz GS, Lapinski RH, WeinR, et al. Race/ethnicity and other risk factors for gestational diabetes.Am J Eidemiol. 1992,135:965.
[8]Wolf M, Sandier L, Hsu K,et al. First-trimester C-reactive Protein and subsequent gestational diabetes.Diabetes Care, 2003,26(3):819-824.
[9]Qiu C,Vadachkofia S,Meryman L,et al.,Maternal plasma concentrations of IGF—1,IGFBP—1, and C—peptide in early pregnancy and subsequent risk of gestational diabetes mellitus.Am J Obstet.Gynecol. 2005,193:1691—1697.
[10]Qiu C,Sorenscn TK,Luthy DA,et al.A prospective study of matermal serum C-reactive protein(CRP) concentrations and risk ofgestational diabetes meallitus Paediat Perinat Epidemiol,2004,18(5): 377-384.
[11]American National Diabetes Data Group.Diabetes 1979,28:1039.
[12]Manson JE,Rimm EB,Colditz GA,et al.Parity and incidence of non-Insulin-dependent- diabetes.Am J Med.,1992,93:13-18.
[13]Homko C,Sivan E,Chen X,et al.Insulin secretion during and after pregnancy in patients with gestational diabetes mellituso J Clin Endocrinol Metab,2001,86(2):568-573.
[14]Buchanan TA,Xiang A,Kjos SL,et.al,Gestational diabetes:antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women,Diabetes,1998,47:1302-1310.
[15]Martin L,Schwartz MD,Wendy NR,et al.The diagnosis and classification of gestational diabetes mellitus:Is it time to change our tune?Am.J.Obstet.Gynecol,1999,180:1560-1571.
[16]Vercellini P,Zuliani G.Pregnancy at forty and over:a case-control study.Eur J Obstet Gynecol Reprod Biol,1993;48:191.
[17]Meier JJ,Nauck MA Glucagon-like peptide 1(GLP-1) in biology and pathology.Diabetes Metab Res Rev.2005,21:91-117.
[18]Sch(a|¨)fer SA,.Tschritter F.,Machicao C et al.,Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2(TCF7L2) gene polymorphisms.Diabetologia 2007;50:2443-2450.
[19]Solomon CG,Willett WC,Carey VJ,et al.,A prospective study of pregnant determinants of gestational diabetes mellitus.JAMA.1997,278:1078-1083.
[20]Martin L,Schwartz MD,Wendy NR,et al.The diagnosis and classification of gestational diabetes mellitus:Is it time to change our tune?Am.J.Obstet.Gynecol,1999,180:1560-1571.
[21]Siribaddana SH,Deshabandu R,Rajapakse D,et al.The prevalence of gestational diabetes in a Sri lankan antenatal clinic.Ceylon.Med.J,1998,43:88-91.
[22]曹泽毅,主编.中华妇产科学[M].北京:人民卫生出版社,1999:508-513.
[23]Florez JC,Jablonski KA,Bayley N et al TCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program.N Engl J Med 2006,355:241-250.
[24]Groves CJ,Zeggini E,Minton J et al Association Analysis of 6,736 UK subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk.Diabetes 2006,55:2640-2644.
[25]Zhang C,Qi L,Hunter DJ et al Variant of transcription factor 7-like 2(TCF7L2) gene and the risk of type 2 diabetes in large cohorts of US women and men.Diabetes 2006, 55:2645-2648. (37) Damcott CM, Pollin TI, Reinhart LJ et al Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish:replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 2006,55:2654-2659.
[26] Scott LJ, Bonnycastle LL, Wilier CJ et al Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 2006,55:2649-2653.
[27]Cauchi S, Meyre D, Dina C et al Transcription factor TCF7L2 genetic study in the French population: expression in human p-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006,55:2903-2908.
[28]Saxena R, Gianniny L, Burtt NP et al Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 2006, 55:2890-2895.
[29]Weedon MN, McCarthy MI, Hitman G et al. Combining information from common type 2 diabetes risk polymorphismsimproves disease prediction. PLoS Med 2006, 3:1-6.
(1) Avery MD, Rossi MA, et al., Gestational diabetes mellitus. J Midwifery, 1994; 39(2 suppl): 9s
(2) Dornhorst A, Paterson CM, Nicholls JSD, et al. High prevalence of gestational diabetes in women from ethnic minority groups. Diabet. Med. 1992; 9: 820-825)
(3) 杨慧霞,董悦,加强对妊娠合并糖尿病的临床研究,中华妇和科杂志,2003,38(3):129。
(4) Homko C,Sivan E,Chen X,et al. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus。 J Clin Endocrinol Metab,2001,86(2):568-573.
(5) Buchanan TA, Xiang A, Kjos SL, et.al, Gestational diabetes:antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women, Diabetes,1998,47: 1302-1310.
(6) YuraS,SagawaN,ItohH,et al., Resistin is expressed in the human placental J Clin Endocrinol Metab,2003,88:139421397.
(7) Martin A.O., Simpson.J.L., Ober.C, et al., Frequency of diabetes Mellitus in mothers of probands with gestational diabetes:possible maternal influence on the predisposition to gestational diabetes,Am J Obstet Gynecol,1985,151:471-475.
(8) PettitD., Aleck K.,Baird H., et al, Congenital susceptibility to NIDDM: role of intrauterine environment J Diabetes, 1988,37(7): 622.
(9) Harder T, Plagemann A,. A role for gestational diabetes in the excess maternal transmission of type 2 diabetes. Diabetes Care, 2000,23(4):431.
(10) Llard S, Beards F, Allen LI,et al., A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria Diabetologia, 2000,43(2): 250-253.
(11) Sagen JV, Baumann ME, Salvesen HB, et al., Diagnostic screening of MODY6 in subjects with MODY or gestational diabetes mellitus. Diabet. Med. 2005,22(8): 1012-1015.
(12) Shaat N, Ekelund M, Lernmark A, et al., Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus. Diabetologia, 2005,48(12):2544-2551.
(13) Rissanen J, Markkanen A, Karkkainen P, et al.,Sulfonylurea receptor gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care, 2000,23(1): 70-73.
(14)Horikawa Y, Oda N, Cox NJ, et al., Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 2000,26(2): 163-175.
(15) Leipold H, Knofler M, Gruber C, et al.,Calpain-10 haplotype combination and association with gestational diabetes mellitus. Obstet. Gynecol. 2004,103(6): 1235-1240.
(16) Alevizaki M,Thalassinou L, Grigorakis SI, et al., Study of the Trg64Arg polymorphism of the beta3-adrenergic receptor in Greek women with gestational diabetes. Diabetes Care,2000,23(8): 1079-1083.
(17) Weedon MN, Schwarz PE, Horikawa Y, et al., Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am J Hum.Genet., 2003, 73(5): 1208-1212.
( 18 ) Festa A, Krugluger W, Shnawa N, et al., Trg64Arg polymorphism of the beta3-adrenergic receptor gene in pregnancy: association with mild gestational diabetes mellitus. J Clin. Endocrinol. Metab., 1999, 84(5): 1695-1699.
(19) Fallucca F, Dalfra MG, Sciullo E, et al., Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy.Metabolism, 2006, 55(11):1451-1456.
(20) Megia A, Gallart L, Fernandez-Real JM, et al., Mannose-binding lectin gene polymorphisms are associated with gestational diabetes mellitus. J Clin. Endocrinol Metab.,2004, 89(10): 5081-5087.
(21) Garcia-Laorden MI, Rua-Figueroa I, Perez-Aciego P, et al., Mannose binding lectin polymorphisms as a disease-modulating fractor in women with systemic lupus erythematosus from Canary Islands,Spain. J Rheumatol. 2003, 30(4):740-746.
(22) Kruse C, Rosgars A, Stefensen R, et al., Lowserum level of mannan binding lectin is a determinant for pregnancy outcome in women with recurrent spontaneous absortion. Am J Obstet Gynecol. 2002, 187(5): 1313-1320.
(23) Duval A, Busson-Leconiat M, Berger R, et al. Assignment of the TCF-4 gene(TCF7L2) to human chromosome band 10q25.3. Cytogenet Cell Genet 2000, 88:264-265.
(24) Duval A. et al. The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings,and mutational analysis in colorectal cancer cell lines. Cancer Res.2000,60: 3872-3879.
(25) Huelsken, J. Birchmeier, W. New aspects of Wnt signaling pathways in higher vertebrates. Curr. Opin. Genet. Dev. 2001, 11: 547-553.
(26) Etheridge SL, Spencer GJ, Heath DJ, et al. Expression profiling and functional analysis of Wnt signaling mechanisms in mesenchymal stem cells. Stem cells 2004;22:849-860.
(27) Yi F, Brubaker PL, Jin T: TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 2005,280:1457-1464.
(28) Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA: Inhibition of adipogenesis by Wnt signaling. Science 2000,289:950 -953.
(29) Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW, Harrison SD,MacDougald OA: Regulation of Wnt signaling during adipogenesis. J Biol Chem 2002,277:30998-31004.
(30) van de Wetering M, Sancho E, Verweij C et al The betacatenin/ TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cell. Cell 2002, 111:241-250.
(31) Jiang Y, Zhou XY, Liu YK, et al. Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma. World J Gastroenterol 2002, 8:804-807.
(32) Papadopoulou S, Edlund H, Edlund H, Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function. Diabetes 2005;54:2844-2851.
(33) Grant SF, Thorleifsson G, Reynisdottir I et al. Variant of transcription 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006,38:320-323.
(34) Florez JC, Jablonski KA, Bayley N et al TCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program. N Engl J Med 2006, 355:241-250.
(35) Groves CJ, Zeggini E, Minton J et al Association Analysis of 6,736 UK subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 2006, 55:2640-2644.
(36) Zhang C, Qi L, Hunter DJ et al Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of US women and men. Diabetes 2006, 55:2645-2648. (37) Damcott CM, Pollin TI, Reinhart LJ et al Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish:replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 2006,55:2654-2659.
(38) Scott LJ, Bonnycastle LL, Wilier CJ et al Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 2006,55:2649-2653.
(39) Cauchi S, Meyre D, Dina C et al Transcription factor TCF7L2 genetic study in the French population: expression in human β-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006,55:2903-2908.
(40) Saxena R, Gianniny L, Burtt NP et al Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 2006, 55:2890-2895.
(41) Weedon MN, McCarthy MI, Hitman G et al. Combining information from common type 2 diabetes risk polymorphismsimproves disease prediction. PLoS Med 2006, 3:1-6.
(42) Loos RJF, Franks PW,Francis RW, et al., TCF7L2 polymorphisms modulate proinsulin levels and 8-cell function in a British Europid population. Diabetes 2007; 56:1943-1947.
(43) Munoz J, Lok KH, Gower BA, et al., Polymorphism in the transcription factor 7-like 2 gene is associated with reduced insulin secretion in non-diabetic women. Diabetes 2006;55:3630-3634.
(44) Freathy RM, Weedon MN, Bennett A, et al., Type 2 diabetes TCF7L2 risk genotypes alter birth weight:a study of 24053 individuals. Am J Hum Genet 2007;80:l 150-1161.
(45) Korinek V, Barker N, Morin PJ, et al., Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997,275:1784-1787.
(46) Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW:Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.Science 1997,275:1787-1790.
(47) Batlle E, Henderson JT, Beghtel H, et al., Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB / ephrinB. Cell 2002,111:251-263.
(48) Korinek V,Barker N,Moerer P,et al.,Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4.Nat Genet 1998,19:379-383.
(49) Meier JJ,Nauck MA Glucagon-like peptide 1(GLP-1) in biology and pathology.Diabetes Metab Res Rev2005,21:91-117.
(50) Sch(a|¨)fer SA,.Tschritter F.,Machicao C et al.,Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2(TCF7L2) gene polymorphisms.Diabetologia 2007;50:2443-2450.